156 related articles for article (PubMed ID: 36309200)
1. DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis.
Yan R; Li J; Xiao Z; Fan X; Liu H; Xu Y; Sun R; Liu J; Yao J; An G; Shi Y; Ge Y
Cell Mol Gastroenterol Hepatol; 2023; 15(2):463-485. PubMed ID: 36309200
[TBL] [Abstract][Full Text] [Related]
2. METTL3 Inhibits Antitumor Immunity by Targeting m
Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
[TBL] [Abstract][Full Text] [Related]
3. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
Li YM; Liu ZY; Wang JC; Yu JM; Li ZC; Yang HJ; Tang J; Chen ZN
Hepatology; 2019 Nov; 70(5):1564-1581. PubMed ID: 31021443
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
[TBL] [Abstract][Full Text] [Related]
5. Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.
Yang J; Yan C; Vilgelm AE; Chen SC; Ayers GD; Johnson CA; Richmond A
Cancer Immunol Res; 2021 Feb; 9(2):200-213. PubMed ID: 33177110
[TBL] [Abstract][Full Text] [Related]
6. CXCR2-Mediated Granulocytic Myeloid-Derived Suppressor Cells' Functional Characterization and Their Role in Maternal Fetal Interface.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
DNA Cell Biol; 2016 Jul; 35(7):358-65. PubMed ID: 27027573
[TBL] [Abstract][Full Text] [Related]
7. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
Taki M; Abiko K; Baba T; Hamanishi J; Yamaguchi K; Murakami R; Yamanoi K; Horikawa N; Hosoe Y; Nakamura E; Sugiyama A; Mandai M; Konishi I; Matsumura N
Nat Commun; 2018 Apr; 9(1):1685. PubMed ID: 29703902
[TBL] [Abstract][Full Text] [Related]
8. Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Zhang J; Yang B; Wang Z
J Exp Clin Cancer Res; 2023 May; 42(1):129. PubMed ID: 37210553
[TBL] [Abstract][Full Text] [Related]
9. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
[TBL] [Abstract][Full Text] [Related]
10. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
Highfill SL; Cui Y; Giles AJ; Smith JP; Zhang H; Morse E; Kaplan RN; Mackall CL
Sci Transl Med; 2014 May; 6(237):237ra67. PubMed ID: 24848257
[TBL] [Abstract][Full Text] [Related]
11. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
[No Abstract] [Full Text] [Related]
12. E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells.
Liang M; Sun Z; Chen X; Wang L; Wang H; Qin L; Zhao W; Geng B
J Exp Clin Cancer Res; 2023 Oct; 42(1):275. PubMed ID: 37865804
[TBL] [Abstract][Full Text] [Related]
13. Targeting m
Bao Y; Zhai J; Chen H; Wong CC; Liang C; Ding Y; Huang D; Gou H; Chen D; Pan Y; Kang W; To KF; Yu J
Gut; 2023 Aug; 72(8):1497-1509. PubMed ID: 36717220
[TBL] [Abstract][Full Text] [Related]
14. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
15. Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer.
Gibson JT; Orlandella RM; Turbitt WJ; Behring M; Manne U; Sorge RE; Norian LA
Front Immunol; 2020; 11():590794. PubMed ID: 33123173
[TBL] [Abstract][Full Text] [Related]
16. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.
Cai B; Liu Y; Chong Y; Zhang H; Matsunaga A; Fang X; Pacholczyk R; Zhou G; Cowell JK; Hu T
Mol Cancer; 2021 Dec; 20(1):165. PubMed ID: 34906138
[TBL] [Abstract][Full Text] [Related]
17. PMN-MDSCs accumulation induced by CXCL1 promotes CD8
Zhou X; Fang D; Liu H; Ou X; Zhang C; Zhao Z; Zhao S; Peng J; Cai S; He Y; Xu J
Cancer Lett; 2022 Apr; 532():215598. PubMed ID: 35176418
[TBL] [Abstract][Full Text] [Related]
18. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
[TBL] [Abstract][Full Text] [Related]
19. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
[TBL] [Abstract][Full Text] [Related]
20. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
